(Journal Article): NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.
 
Ghosh S, May MJ, Kopp EB (Section of Immunobiology, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut 06520, USA., sankar.ghosh@yale.edu )
 
IN: Annu Rev Immunol 1998; 16(1):225-260
Impact Factor(s) of Annu Rev Immunol: 47.4 (2005), 52.431 (2004), 52.28 (2003), 54.455 (2002), 46.233 (2001)

Fulltext:    HTML  PDF

ABSTRACT: The transcription factor NF-kappa B, more than a decade after its discovery, remains an exciting and active area of study. The involvement of NF-kappa B in the expression of numerous cytokines and adhesion molecules has supported its role as an evolutionarily conserved coordinating element in the organism's response to situations of infection, stress, and injury. Recently, significant advances have been made in elucidating the details of the pathways through which signals are transmitted to the NF-kappa B:I kappa B complex in the cytosol. The field now awaits the discovery and characterization of the kinase responsible for the inducible phosphorylation of I kappa B proteins. Another exciting development has been the demonstration that in certain situations NF-kappa B acts as an anti-apoptotic protein; therefore, elucidation of the mechanism by which NF-kappa B protects against cell death is an important goal. Finally, the generation of knockouts of members of the NF-kappa B/I kappa B family has allowed the study of the roles of these proteins in normal development and physiology. In this review, we discuss some of these recent findings and their implications for the study of NF-kappa B.

TYPE OF PUBLICATION: Review

Articles citing this article:

• Sia C. Is a New Immune Response Mediator in the NF-κB pathway - SUMO-4 - Related to Type 1 Diabetes? Rev Diabetic Stud 2005. 2: 58-60.
  » Diabetes OD » Diabetes Pathogenesis » T1DM » Autoimmunity » Genetics of Autoimmunity » SUMO4 » Journal Article